Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeInvestment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxRevenueShares Outstanding (Weighted Average)Tax Rate
Others
Ratios

NewGenIvf (NIVF) EBITDA: 2021-2024

Historic EBITDA for NewGenIvf (NIVF) over the last 4 years, with FY2024 value amounting to -$441572.0.

  • NewGenIvf's EBITDA fell 8709878472.09% to -$249.7 billion in Q3 2025 from the same period last year, while for Sep 2025 it was -$230.8 billion, marking a year-over-year change of. This contributed to the annual value of -$441572.0 for FY2024, which is 61516.91% down from last year.
  • According to the latest figures from FY2024, NewGenIvf's EBITDA is -$441572.0, which was down 61516.91% from $85714.0 recorded in FY2023.
  • NewGenIvf's EBITDA's 5-year high stood at $133927.0 during FY2022, with a 5-year trough of -$441572.0 in FY2024.
  • For the 4-year period, NewGenIvf's EBITDA averaged around -$88178.0, with its median value being -$22533.5 (2021).
  • Per our database at Business Quant, NewGenIvf's EBITDA surged by 20240.55% in 2022 and then tumbled by 61516.91% in 2024.
  • Annual analysis of 4 years shows NewGenIvf's EBITDA stood at -$130781.0 in 2021, then soared by 202.41% to $133927.0 in 2022, then crashed by 36.0% to $85714.0 in 2023, then crashed by 615.17% to -$441572.0 in 2024.
  • Its EBITDA was -$441572.0 in FY2024, compared to $85714.0 in FY2023 and $133927.0 in FY2022.